Federal Supreme Court Confirms Compulsory License by Way of a Preliminary Injunction
In March our partner Hetti Hilge reported on a preliminary injunction by which the Federal Patent Court granted Merck an interlocutory compulsory license for Merck’s HIV drug Isentress in the light of Shionogi’s Raltegravir patent EP 1 422 218 (link). The compusory license has now been confirmed in the second instance PI proceedings by the…